EDGAR Filing Documents for 0001274644-16-000088

Form 8-K - Current report:

SEC Accession No. 0001274644-16-000088

Filing Date

2016-01-08

Accepted

2016-01-08 16:03:24

Documents

Period of Report

2016-01-05

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K- OCERA NEW CMO AND CFO EMPLOYMENT AGREEMENT	ocera-form8xkx502newcmoand.htm	8-K	47314
2	EXHIBIT 10.1- NEW CMO EMPLOYMENT AGREEMENT	ocera-bukofzeremploymentag.htm	EX-10.1	112170
3	EXHIBIT 10.2- CFO EMPLOYMENT AGREEMENT	ocera-byrnesemploymentagre.htm	EX-10.2	106842
4	EXHIBIT 99.1- PRESS RELEASE ANNOUNCING APPOINTMENT OF CMO	oceraappointsdrstanbukofze.htm	EX-99.1	10384
5	EXHIBIT 99.2 - PRESS RELEASE ANNOUNCING ADDITIONAL PHASE 1 ORAL DATA	oceraannouncesadditionalpo.htm	EX-99.2	18412
6		oceraannouncesadditio_image1.gif	GRAPHIC	18876
7		oceraannouncesadditio_image2.gif	GRAPHIC	22898
8		oceraannouncesadditio_image3.jpg	GRAPHIC	11182
9	OCERA LOGO	oceraappointsdrstanbuimage1a.jpg	GRAPHIC	11182
	Complete submission text file	0001274644-16-000088.txt		385133

Mailing Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301

Business Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301 6504625800

Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)